NCT07188025 - ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer | Biotech Hunter

Enrollment

103

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2030

Study Completion Date

October 31, 2035

Conditions

Rectal Cancer

Interventions

DRUG

Adjuvant chemotherapy

Adjuvant chemotherapy consists of 6 cycles of 5FU/folinic acid and oxaliplatin (FOLFOX) every 2 weeks, or 4 cycles of capecitabine and oxaliplatin (CAPOX). Duration of treatment will be 3 months (12 weeks).